Inflammatory serum markers in patients with multiple trauma. Can they predict outcome?
Giannoudis
P V
PV
Department of Trauma and Orthopaedic Surgery, St James's University Hospital, Leeds, England.
Hildebrand
F
F
Pape
H C
HC
D000209:Acute-Phase Proteins / Q000032:analysis; D015415:Biomarkers / Q000097:blood*; D002116:Calcitonin / Q000097:blood; D002352:Carrier Proteins / Q000097:blood; D015815:Cell Adhesion Molecules / Q000097:blood; D015802:HLA-DR2 Antigen / Q000097:blood; D006801:Humans; D007249:Inflammation / Q000097:blood*; D007378:Interleukins / Q000097:blood; D008562:Membrane Glycoproteins; D009102:Multiple Organ Failure / Q000097:blood*; D010196:Pancreatic Elastase / Q000097:blood; D011498:Protein Precursors / Q000097:blood; D018121:Receptors, Cytokine / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D000099231:Lipopolysaccharide-Binding Protein
D000209:Acute-Phase Proteins; D015415:Biomarkers; D002116:Calcitonin; D002352:Carrier Proteins; D015815:Cell Adhesion Molecules; D015802:HLA-DR2 Antigen; D007378:Interleukins; D008562:Membrane Glycoproteins; D010196:Pancreatic Elastase; D011498:Protein Precursors; D018121:Receptors, Cytokine; D014409:Tumor Necrosis Factor-alpha; D000099231:Lipopolysaccharide-Binding Protein